128 related articles for article (PubMed ID: 11093276)
21. New insights into the Fanconi anemia pathway from an isogenic FancG hamster CHO mutant.
Tebbs RS; Hinz JM; Yamada NA; Wilson JB; Salazar EP; Thomas CB; Jones IM; Jones NJ; Thompson LH
DNA Repair (Amst); 2005 Jan; 4(1):11-22. PubMed ID: 15533833
[TBL] [Abstract][Full Text] [Related]
22. Identification of Alu-mediated deletions in the Fanconi anemia gene FAA.
Levran O; Doggett NA; Auerbach AD
Hum Mutat; 1998; 12(3):145-52. PubMed ID: 9711872
[TBL] [Abstract][Full Text] [Related]
23. [Chart 48: FANCG/XRCC9 (type G Fanconi's anemia)].
Soussi T
Bull Cancer; 2001 Dec; 88(12):1149-50. PubMed ID: 11792607
[No Abstract] [Full Text] [Related]
24. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
25. The fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex.
Garcia-Higuera I; Kuang Y; Denham J; D'Andrea AD
Blood; 2000 Nov; 96(9):3224-30. PubMed ID: 11050007
[TBL] [Abstract][Full Text] [Related]
26. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
[TBL] [Abstract][Full Text] [Related]
27. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract][Full Text] [Related]
28. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment.
Futaki M; Watanabe S; Kajigaya S; Liu JM
Biochem Biophys Res Commun; 2001 Feb; 281(2):347-51. PubMed ID: 11181053
[TBL] [Abstract][Full Text] [Related]
29. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells.
Xie Y; de Winter JP; Waisfisz Q; Nieuwint AW; Scheper RJ; Arwert F; Hoatlin ME; Ossenkoppele GJ; Schuurhuis GJ; Joenje H
Br J Haematol; 2000 Dec; 111(4):1057-64. PubMed ID: 11167740
[TBL] [Abstract][Full Text] [Related]
30. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity.
Kuang Y; Garcia-Higuera I; Moran A; Mondoux M; Digweed M; D'Andrea AD
Blood; 2000 Sep; 96(5):1625-32. PubMed ID: 10961856
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of the putative peroxidase domain of FANCA, the Fanconi anemia complementation group A protein.
Ren J; Youssoufian H
Mol Genet Metab; 2001 Jan; 72(1):54-60. PubMed ID: 11161829
[TBL] [Abstract][Full Text] [Related]
32. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
[TBL] [Abstract][Full Text] [Related]
33. Four human FANCG polymorphic variants show normal biological function in hamster CHO cells.
Hinz JM; Nham PB; Yamada NA; Tebbs RS; Salazar EP; Hinz AK; Mohrenweiser HW; Jones IM; Thompson LH
Mutat Res; 2006 Dec; 602(1-2):34-42. PubMed ID: 17010390
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the hamster FancG/Xrcc9 gene and mutations in CHO UV40 and NM3.
Lamerdin JE; Yamada NA; George JW; Souza B; Christian AT; Jones NJ; Thompson LH
Mutagenesis; 2004 May; 19(3):237-44. PubMed ID: 15123790
[TBL] [Abstract][Full Text] [Related]
35. Chemosensitizing tumor cells by targeting the Fanconi anemia pathway with an adenovirus overexpressing dominant-negative FANCA.
Ferrer M; de Winter JP; Mastenbroek DC; Curiel DT; Gerritsen WR; Giaccone G; Kruyt FA
Cancer Gene Ther; 2004 Aug; 11(8):539-46. PubMed ID: 15192709
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology of Fanconi anaemia--an old problem, a new insight.
Ahmad SI; Hanaoka F; Kirk SH
Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
[TBL] [Abstract][Full Text] [Related]
37. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
Levran O; Attwooll C; Henry RT; Milton KL; Neveling K; Rio P; Batish SD; Kalb R; Velleuer E; Barral S; Ott J; Petrini J; Schindler D; Hanenberg H; Auerbach AD
Nat Genet; 2005 Sep; 37(9):931-3. PubMed ID: 16116424
[TBL] [Abstract][Full Text] [Related]
38. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
39. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
Levitus M; Waisfisz Q; Godthelp BC; de Vries Y; Hussain S; Wiegant WW; Elghalbzouri-Maghrani E; Steltenpool J; Rooimans MA; Pals G; Arwert F; Mathew CG; Zdzienicka MZ; Hiom K; De Winter JP; Joenje H
Nat Genet; 2005 Sep; 37(9):934-5. PubMed ID: 16116423
[TBL] [Abstract][Full Text] [Related]
40. Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9.
Yang Y; Kuang Y; Montes De Oca R; Hays T; Moreau L; Lu N; Seed B; D'Andrea AD
Blood; 2001 Dec; 98(12):3435-40. PubMed ID: 11719385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
